Marico Q2 FY27 slides: record profit growth, raised EBITDA guidance

Marico reported Q2 FY27 revenue growth of 13% to ₹3,897 crore, EBITDA growth of 27% to ₹709 crore, and PAT growth of 31% to ₹550 crore; EBITDA margin expanded 200 bps to 18.2%. The company raised FY27 guidance to mid-twenties EBITDA growth from approximately 20% previously, with 120–150 bps of margin expansion and teens revenue growth, while its shares were down 0.18% at ₹798.55. Key risks include input-cost volatility and food inflation, although softer copra prices, volume growth, and portfolio premiumization supported results.

Analysis

The earnings signal is less clean than headline profit growth implies: unusually favorable copra costs appear to have more than offset inflation in other inputs, while advertising and operating costs rose quickly. The key question is whether gross-margin gains persist after the commodity tailwind fades—not whether one quarter’s EBITDA growth can be repeated. If copra reverses, selective price cuts on loyalty packs could make margin recovery harder without sacrificing the volume gains they were designed to buy.

Over 1–3 months, watch gross margin, India volume and the H2 guidance bridge. SETU 2.0 could improve distribution productivity, but AI-enabled selling and digital-to-general-trade expansion are execution claims until incremental sales cover associated costs. Likewise, the Saffola oil reset needs evidence of improved mix and contribution, not just value growth alongside declining volumes. Over 6–18 months, a larger premium/digital mix could lower commodity sensitivity, but projected scale and margin milestones remain execution-dependent; international diversification also exchanges Bangladesh concentration for FX and local-market risk.

The contrarian read: the muted reaction may underweight the possibility that cost relief is temporary, but the optimistic long-term mix narrative could also be discounted too heavily if digital brands achieve scale without durable profitability. No valuation or peer-relative data are supplied, so this is not a high-conviction outright long. Thesis weakens if input-cost inflation returns and margins contract despite sustained volume, or if management cuts FY27 guidance; it strengthens if H2 margins hold while advertising intensity remains elevated.

Key Decisions for Investors

• Avoid chasing the quarter; use the next results or management update to verify how much EBITDA improvement came from lower copra versus durable mix, pricing and productivity.
• Watchlist: consider a staged long in Marico only if India volume remains healthy and gross-margin resilience is demonstrated through a copra-cost reversal. Define the invalidation as margin contraction accompanied by weaker volumes or a guidance downgrade.
• Treat the digital/premium expansion as an alert, not a standalone buy thesis: seek segment-level revenue, repeat-purchase and EBITDA evidence showing that growth is translating into profitable contribution.
• Monitor Saffola edible-oil volumes and contribution after the portfolio reset. Continued volume declines without improving profitability would challenge management’s repositioning case.